Masterclass in Clinical Oncology - Summer edition

Applications closed.

Chairs: A. Eniu, CH; A. Pasic, BA
Host Chairs: C. Sessa, CH; F. Sessa, IT

Aims, objectives and teaching format

The ESO Masterclass is a full immersion, clinical oriented event designed for medical and clinical oncologists with 3-4 years experience in oncology who would like to receive further training on the treatment of tumours from a multidisciplinary point of view. The programme exposes participants to a full spectrum of issues in clinical oncology and to practice-oriented training.
The Masterclass is organized into:

• Plenary lectures on state-of-the-art clinical treatments with reference to clinical guidelines given by renowned international faculty.

•  

  Interactive workshops on communication, ethics and managing burnout.

• Clinical case presentations/tumour board simulation where each participant presents and discusses a case with an international faculty of top experts in each tumour type.

The Masterclass is divided into two educational parts:

1. Pre-recorded online lectures
2. In-person event

The online lectures are released before the in-person event to give each participant the opportunity to prepare themselves in their own time and at their own pace.

The in-person event is held in the style of a 3-and-half-day ‘retreat’, giving participants the opportunity to begin building an international oncology network as well as the chance to interact with renowned faculty in an informal environment over a number of days.

The Masterclass is held entirely in English and fluency in English is necessary for admission.

The ESO Masterclass in Clinical Oncology: Summer edition is a closed event for selected participants only.

LANGUAGE

The Masterclass will be held in English and translation will not be provided.

FEE

The Masterclass will take place at UnaHotels in Varese (Milan area), Italy.

A fee of:

• 300 EUR for participant working in High-Middle Income Countries *
• 200 EUR for participants working in Low-Middle income countries *

covers:

• Access to the course and its educational resources
• Accommodation for 4 nights at UnaHotels in Varese
• Group transfer from Malpensa airport to the Masterclass venue
• Meals according to the programme

The fee does not cover travel costs, these should be organized and paid by the participant.

A discount of 30 EUR is given to participants who are already ESCO members.

*as defined by the World Bank

The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.

ACCREDITATION

Participants will be issued a certificate of attendance (minimum attendance: 75% of the online part + 100% of the in-person event). An online evaluation questionnaire and learning assessment test will need to be completed for both parts in order to get the certificate that will be sent by email.
Application for CME recognition has been submitted and the Masterclass has been awarded with 39 Credits by the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

     ESCO - The ESO College

Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enroll in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

Should you have any queries, please do not hesitate to contact the event organisers:
Alice Ciocchini – aciocchini@eso.net
Dolores Knupfer – dknupfer@eso.net

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY.

60 PARTICIPANTS WILL BE SELECTED.

Applications closed.

IDEAL PROFILE OF THE MASTERCLASS CANDIDATE

• Aged up to 40 years
• 2-3 years’ experience in medical oncology
• Involvement in scientific activities and clinical trials
• Fluency in English
• From ESO’s geographical reach

HOW TO APPLY

Interested oncologists should apply online (at the top of this page) providing:

• Letter describing motivation for attending;
• Supporting letter from head of department or mentor;
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
• Clinical case (please, use the provided template below)
• Professional experience form (please, use the provided template below)

CLINICAL CASE PRESENTATION

During the in-person event all participants will have the chance to present a clinical case as a clinical grandround discussion to the faculty and participants. A template giving details of the clinical case you would like to present should be submitted with your application. Please provide a straightforward case found in your daily clinical practice - no uncommon or extremely rare cases. You should include

• Diagnostic considerations
• Treatment
• Results, follow-up
• At least three questions proposed for discussion with the faculty

If you are selected for the Masterclass, you will be asked to prepare a PowerPoint presentation of your case (max 10 slides). If we receive too many cases from one tumour group, we may ask you to change the case topic you submitted during your application. We kindly ask you to let us know your 2^nd choice topic if your first choice cannot be accommodated.

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Clinical Case template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

TEMPLATES

• Download HERE your Professional experience template
• Download HERE your Clinical case template

Joerg Beyer, University Hospital of Bern, CH
Consuelo Buttigliero, San Luigi Gonzaga Hospital, Genitourinary Dpt., Torino, IT
Felipe A. Calvo Manuel, Clinica Universidad de Navarra, Dept. of Radiation Oncology, Madrid, ES
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, PT
Jvan Casarin, University of Insubria, Surgery Dpt., Lonate Pozzolo, IT
Ian Chau, Royal Marsden Hospital, Department of Medicine, Sutton, Surrey, UK
Nicoletta Colombo, Istituto Europeo di Oncologia, Unità di Ginecologia Oncologica, Milano, IT
Agnes Csikos, Palliative Hospice Tanszék, Palliative Care Dpt., Pecs, HU
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Andre D'Hoore, UZ Gasthuisberg, Dept. of Surgery, Leuven, BE
Rodrigo Dienstmann, Vall d’Hebron Institute of Oncology, Molecular Therapeutic Research Unit, Barcelona, ES
Andreas Dietz, University Hospital Leipzig, ENT Dpt., Leipzig, DE
Rafal Dziadziuszko, Medical University of Gdansk, Oncology and Radiotherapy Dpt., Gdansk, PL
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Lesley Fallowfield, SHORE-C, Brighton & Sussex Medical School, Brighton, UK
Martin Früh, St. Gallen Cantonal Hospital, Dept. of Internal Medicine, St. Gallen, CH
Andrea Gallina, EOC - Ente Ospedaliero Cantonale, Urology Dpt., Bellinzona, CH
Marina Garassino, University of Chicago Medicine & Biological Sciences, Section of Hematology | Oncology, Chicago, US
Fady B. Geara, Cleveland Clinic Abu Dhabi, Dept. of Radiation Oncology, Abu Dhabi, AE
Fabio Ghezzi, ASST dei Sette Laghi, Gynaecology Dpt., Varese, IT
Federica Grosso, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, ., Alessandria, IT
Andrew Hoy, Independent Palliative Medicine Practice, Epsom, UK
Andrea Imperatori, University of Insubria, Lung Cancer Dpt., Varese, IT
Barbara Alicja Jereczek-Fossa, European Institute of Oncology, Dept. of Radiotherapy, Milano, IT
Izidor Kern, University Clinic Golnik, Dept. of Pathology, Golnik, SI
Stephanie Kroeze, University Hospital Zurich, Radio-Oncology Dept., Zurich, CH
Beata Laki, Medical School, University of Pécs, Department of Behavioural Sciences, Pécs, HU
Matteo Lambertini, University of Genova - San Martino Hospital, Genoa, IT
Domenica Lorusso, Gemelli University Hospital, Gynecological Oncology Unit, Roma, IT
Luca Mazzucchelli, Ente Ospedaliero Cantonale, Institute of Pathology, Bellinzona, CH
Francesco Meani, Centro di Senologia Cliniche Moncucco e Santa Chiara, Centro di Senologia, Lugano, CH
Andrea Necchi, IRCCS San Raffaele Hospital, Genitourinary Medical Oncology Division, Milan, IT
Radka Obermannova, Masaryk Memorial Cancer Institute, Brno, CZ
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Demetris Papamichael, Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY
Anes Pasic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Gianfranco Angelo Pesce, Oncology Institute of Southern Switzerland (IOSI), Radiooncology Dept., Bellinzona, CH
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Amanda Psyrri, Attikon University Hospital, Medical Oncology Dept., Chaidari, GR
Isabelle Ray-Coquard, Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR
Christian Rolfo, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Center for Thoracic Oncology, New York, US
Laura Rubbia-Brandt, Hôpitaux Universitaires Genève, Pathology Dept., Geneve, CH
Manuela Schmidinger, Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, AT
Uta Schmidt-Strassburger, Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE
Isabelle Schmitt-Opitz, University of Zurich Hospital, Dept. of Thoracic Surgery, Zurich, CH
Cristiana Sessa, Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH
Fausto Sessa, University Insubria, Pathology Dpt., Varese, IT
Thomas Seufferlein, Ulm University Hospital, Dept. of Internal Medicine I, Ulm, DE
Pelagia Tsoutsou, Hôpitaux Universitaires de Genève (HUG), Radiation Oncology Dpt., Geneve, CH
Mariacarla Valli, Cantonal Hospital of Southern Switzerland (EOC), Dept. of Radiotherapy, Bellinzona, CH
Eric Van Cutsem, University Hospital Leuven, Digestive Oncology Dept., Leuven, BE
Alberto Vannelli, Ospedale Valduce, General Surgery Dpt., Como, IT
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH
Ignacio Zapardiel, La Paz University Hospital, Gynecologic Oncology Unit, Madrid, ES